Rekombinanter C9 Antikörper (C-Term)
Kurzübersicht für Rekombinanter C9 Antikörper (C-Term) (ABIN7857684)
Target
Alle C9 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- C-Term
-
Expressionssystem
- CHO Cells
-
Verwendungszweck
- Recombinant Complement Component C9 (CCC9) (Early Myocardial Infarction Marker) Antibody
-
Spezifität
- Complement component C9 binds to the C5b-8 complex as the final protein of the membrane attack complex. After binding, it undergoes a conformational change and inserts itself into the cell membrane, forming transmembrane channels. Complement component C9 acts in a similar way to perforin, a pore forming protein found in cytotoxic T cells. Male and female reproductive tissues express and synthesize complement components, binding proteins and receptors, although the implications of this are unclear.
-
Aufreinigung
- 200ug/ml of Ab produced in CHO cell mammalian-based expression system.
-
Immunogen
- Prokaryotic recombinant protein corresponding to a C-terminal region of the complement component C9 molecule.
-
Isotyp
- IgG1, kappa
-
-
anti-Complement Component C9 (C9) (AA 191-220), (Center) antibody
C9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33918 unconjugated
anti-Complement Component C9 (C9) (AA 22-265) antibodyC9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 136-512) antibodyC9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 139-519) antibody (APC)C9 Reaktivität: Kaninchen WB, IHC Wirt: Meerschweinchen Polyclonal APC
anti-Complement Component C9 (C9) (AA 191-220) antibodyC9 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 336-554) antibodyC9 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 205-216) antibodyVerified C9 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 184-411) antibodyC9 Reaktivität: Human WB, ICC, IHC (p), IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 289-515) antibodyC9 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- C9 (Complement Component C9 (C9))
-
Andere Bezeichnung
- Complement Component C9
-
Hintergrund
-
Complement component C9a | Complement component C9b
Human liver, placenta, myocardium or rejected renal transplant tissue.
-
Molekulargewicht
- 71kDa
-
Gen-ID
- 735
-
UniProt
- P02748
-
Pathways
- Komplementsystem
Target
-
